Tuesday, 10th November
8th Australasian Vaccines & Immunotherapeutics Development Meeting 2020
Days
Monday, 9th November
Tuesday, 10th November
Search
Speakers
Session 5: Immunotherapies
11:00AM - 12:00PM
Tuesday, 10th November
Chairs: Phillip Darcy & Rajiv Khanna
Sponsored by:
STEMCELL Technologies Inc
Effective killing of acute myeloid leukemia by TIM-3 targeted chimeric antigen receptor T cells
-
Sandy Lee
Enhancing tumor-intrinsic signaling to prevent the metastatic spread of cancer cells to bone
-
Katie Owen
Phase I clinical trial using gene-modified T cells within an academic setting
-
Siok Tey
Break
12:00PM - 12:10PM
Tuesday, 10th November
Session 6: Inflammation/Anitbody Therapies
12:10PM - 1:10PM
Tuesday, 10th November
Chairs: Subhra k Biswas & Christina Scheffler
Targeting Tumour-associated Macrophages
-
Toby Lawrence
Developing antibody-based tools for the diagnosis and treatment of Dengue
-
Paul Macary
Overcoming tumour heterogeneity by engaging host immunity to enhance chimeric antigen receptor (CAR) T cell therapy of solid cancers
-
Junyun Lai
Break
1:10PM - 1:25PM
Tuesday, 10th November
Session 7: Viral Immunity
1:25PM - 2:25PM
Tuesday, 10th November
Chairs: Rosemary Ffrench & Junyun Lai
Sponsored by:
Mimotopes
A point of care lateral flow assay for immunity to Covid-19
-
Dale Godfrey
Cellular and molecular mechanisms of viral infections: from diagnostics to therapies
-
Lisa Ng
T cell response against SARS-CoV2
-
Antonio Bertoletti
Break
2:25PM - 2:35PM
Tuesday, 10th November
Session 8: Virtual Poster Presentations
2:35PM - 3:25PM
Tuesday, 10th November
Chairs: Gabrielle Belz & Rosemary Ffrench
Using synthetic biology to generate hyper-stable vaccines
-
John Miles
Effective targets of cross-species protective immunity against malaria identified by proteome-wide screening
-
Denise Doolan
Rapid inactivation and deletion of adoptively transferred CTL upon encounter with a high number of antigen presenting lymphoma cells
-
Christina Scheffler
Stem cell memory like CAR-T cells persist better in vivo and induce solid tumour complete regression in combination with anti-PD1.
-
Paul J Neeson
Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells
-
Rong En Tay
TCR repertoire and transcriptome differs between optimal HLA-A*02:01- and high-risk HLA-A*24:02-restricted CD8
+
T cell immunity against influenza A virus
-
So Young Chang
The discovery of molecular regulatory mechanism of MR1 antigen presentation
-
Hui Jing Lim
Optimising novel adjuvant formulations to promote protective immunity without reactogenicity
-
Diana H Quan
Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction
-
Erica Stewart
Poster Presentation - 3 minute Pre-Recorded Video
12:01AM - 11:59PM
Tuesday, 10th November
Plasmodium
-induced interferon-γ restricts O’nyong-nyong virus replication and dissemination in mouse tissues
-
Anthony Torres-Ruesta
Bile acid-based delivery system for lipopeptide vaccine against Group A Streptococcus
-
Armira Azuar
Development of glycan-based vaccine candidates to protect against
streptococcus pyogenes
-
Asmaa Mahmoud
Polyethylenimine: an intranasal adjuvant for liposomal peptide-based subunit vaccine against group A
Streptococcus
-
Charles C. Dai
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant
-
Cheryl Yi-Pin Lee
Prophylactic vaccination protects mouse sperm quality afte
r Chlamydia muridarum
challenge
-
Emily R Bryan
Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19
-
Guillaume Carissimo
Structure-activity analysis of a self-adjuvanting cyclic lipopeptide delivery system for group a s
treptococcus
peptide antigens
-
Harrison Y.R. Madge
M-protein based vaccine induces immunogenicity and protection from
Streptococcus pyogenes
when delivered on a high-density microarray patch (HD-MAP)
-
Jamie-lee S Mills
Delivery of a peptide-based vaccine against Group A Streptococcus with the help of cell penetrating peptides
-
Jieru Yang
Development of a DNA vaccine that provides protection against blood stage malaria
-
Maria A Soliman
Development and evaluation of a peptide based liposomal blood-stage malaria vaccine
-
MD TANJIR ISLAM
Structure–Activity Relationship of Lipopeptide-anchored Liposomes Vaccine Candidates
-
Nedaa Alharbi
Development of spherical, rod and worm shaped polymer based delivery system for peptide vaccine to treat Group A Streptococci (GAS) infection
-
Prashamsa Koirala
Lung endothelial cell antigen cross-presentation to CD8
+
T cells: With an angle to hamper CD8
+
T cells pathogenesis in malaria-associated lung injury
-
Samantha Nguee
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity
-
Siti Naqiah Amrun
Development of C-type Lectin Receptor Targeting Subunit Vaccine Against Group a Streptococcus (GAS)
-
Ummey Jannatun Nahar
Development of peptide based subunit vaccine for Tuberculosis
-
Viet Tram Duong
Unraveling immunity towards seasonal influenza vaccine in haematopoietic stem cell transplant recipients
-
Wuji Zhang
Sensitive detection of total anti-Spike antibodies and isotype switching in asymptomatic and symptomatic COVID-19 patients
-
Yun Shan Goh
← Monday